v3.26.1
Common Stock
3 Months Ended
Mar. 31, 2026
Stockholders' Equity Note [Abstract]  
Common Stock

8. Common Stock

 

As of March 31, 2026 and December 31, 2025, the Company’s certificate of incorporation authorized the Company to issue 300,000,000 shares of common stock at a par value of $0.0001 per share. Each share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Company’s board of directors. As of March 31, 2026 and December 31, 2025, no dividends have been declared to date.

 

The Company has completed several underwritten public follow-on offerings, from which shares of common stock and pre-funded warrants were issued. As of March 31, 2026, the following aggregate warrants to purchase shares of the Company’s common stock were issued and outstanding:

 

Issue Date

 

Expiration Date

 

Exercise Price per Share

 

 

Number of Shares subject to Outstanding Warrants

 

July 11, 2024

 

None

 

$

0.0001

 

 

 

285,715

 

October 27, 2023

 

None

 

$

0.0001

 

 

 

319,150

 

April 27, 2023

 

None

 

$

0.0001

 

 

270,270(1)

 

(1) In September 2024, 1,750,000 shares of common stock subject to outstanding pre-funded warrants were

cashless exercised and 1,749,993 shares of common stock were issued.

 

The warrants are classified as a component of Stockholders’ Equity within Additional Paid-in-Capital. The warrants are classified as equity because they are freestanding financial instruments that are legally detachable and separately exercisable from the equity instruments, are immediately exercisable, do not embody an obligation for the Company to repurchase its shares, are indexed to the Company’s common stock and meet the equity classification criteria. The warrants will not expire until they are fully exercised.

 

The Company had reserved common stock for future issuance as follows:

 

 

 

March 31,

 

December 31,

 

 

2026

 

2025

Exercise of outstanding options under the 2015, 2019 and 2023 Plans

 

14,825,324

 

11,130,405

Shares available for grant under the 2019 Plan

 

3,007,833

 

2,833,979

Shares available for grant under the 2023 Inducement Plan

 

1,100,263

 

1,516,767

Shares available under the Employee Stock Purchase Plan

 

3,565,724

 

2,687,759

Pre-funded warrants issued and outstanding

 

875,135

 

875,135

Total

 

23,374,279

 

19,044,045